Peiwei Yang
Impact in
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Oncology 6
- CAR-T cell therapy research 6
- Cancer Immunotherapy and Biomarkers 1
-
- Cancer-related molecular mechanisms research 2
- Co-authors
- Mengwei Li (4 shared papers)Hanmei Xu (5 shared papers)Heming Wu (4 shared papers)Shou‐Mei Wang (3 shared papers)Xiaojun Feng (3 shared papers)Hanmei Xu (2 shared papers)Erhao Zhang (2 shared papers)Lin Chen (1 shared paper)
In The Last Decade
Peiwei Yang
14 papers receiving 557 citations
Peers
Comparison fields: 5 of 58
- Oncology 177
- Cancer Research 105
- Aging 7
- Pharmacology 45
- Molecular Biology 159
Countries citing papers authored by Peiwei Yang
This map shows the geographic impact of Peiwei Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peiwei Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peiwei Yang more than expected).
Fields of papers citing papers by Peiwei Yang
This network shows the impact of papers produced by Peiwei Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peiwei Yang. The network helps show where Peiwei Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Peiwei Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 89 | |
| 2 | 2021 | 80 | |
| 3 | 2019 | 63 | |
| 4 | 2020 | 62 | |
| 5 | 2018 | 48 | |
| 6 | 2020 | 48 | |
| 7 | 2021 | 43 | |
| 8 | 2022 | 30 | |
| 9 | 2021 | 29 | |
| 10 | 2020 | 25 | |
| 11 | 2022 | 21 | |
| 12 | 2023 | 15 | |
| 13 | 2024 | 13 | |
| 14 | 2017 | 1 | |
| 15 | 2026 | 0 |
About Peiwei Yang
Peiwei Yang is a scholar working on Oncology, Cancer Research, Pharmacology, Otorhinolaryngology and Complementary and alternative medicine, having authored 15 papers that have together received 567 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Flavonoids in Medical Research (3 papers), Cancer-related molecular mechanisms research (2 papers), Telomeres, Telomerase, and Senescence (1 paper), SARS-CoV-2 detection and testing (1 paper), Head and Neck Cancer Studies (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Circular RNAs in diseases (1 paper). The work is most often cited by research in Oncology (177 citations), Cancer Research (105 citations), Aging (7 citations), Pharmacology (45 citations) and Molecular Biology (159 citations). Peiwei Yang has collaborated with scholars based in China, Australia and France. Frequent co-authors include Mengwei Li, Hanmei Xu, Heming Wu, Shou‐Mei Wang, Xiaojun Feng, Hanmei Xu, Erhao Zhang, Lin Chen, Shu‐Hui Zhang and Ying Wang. Their work appears in journals such as Journal of the American Chemical Society, Cell Death and Disease, Signal Transduction and Targeted Therapy, Journal of Hematology & Oncology and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.